HappeningToo topic
Mepolizumab reports
Browse community reports connected to Mepolizumab. These reports can show that other people are describing similar experiences, but they do not prove that Mepolizumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
29 problems
Abdominal Discomfort while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and abdominal discomfort appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and abdominal pain upper appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and acid reflux appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and alopecia appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and anxiety appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and back pain appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and chest discomfort appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and cough appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and diarrhea appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and dizziness appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and dry mouth appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and fatigue appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and headache appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and hives appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and insomnia appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and itching appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and malaise appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and migraine appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and muscle spasms appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and nausea appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and pain appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and rash appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and shortness of breath appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and sleep disorder appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and swelling appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and tingling or pins and needles appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and vomiting appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and weakness appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Mepolizumab
FDA FAERS contains adverse-event reports in which Mepolizumab and weight increased appear together. This does not establish that Mepolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →